<code id='9D2972EBBA'></code><style id='9D2972EBBA'></style>
    • <acronym id='9D2972EBBA'></acronym>
      <center id='9D2972EBBA'><center id='9D2972EBBA'><tfoot id='9D2972EBBA'></tfoot></center><abbr id='9D2972EBBA'><dir id='9D2972EBBA'><tfoot id='9D2972EBBA'></tfoot><noframes id='9D2972EBBA'>

    • <optgroup id='9D2972EBBA'><strike id='9D2972EBBA'><sup id='9D2972EBBA'></sup></strike><code id='9D2972EBBA'></code></optgroup>
        1. <b id='9D2972EBBA'><label id='9D2972EBBA'><select id='9D2972EBBA'><dt id='9D2972EBBA'><span id='9D2972EBBA'></span></dt></select></label></b><u id='9D2972EBBA'></u>
          <i id='9D2972EBBA'><strike id='9D2972EBBA'><tt id='9D2972EBBA'><pre id='9D2972EBBA'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:4962
          ACT UP protest
          A demonstration marking the 10th anniversary of the formation ACT UP, in New York. Mark Lennihan/AP

          WASHINGTON — Next Wednesday, a cadre of ALS patients will gather for a protest outside the FDA’s headquarters in suburban Maryland with a clear message: “No More Excuses.”

          The rally is being organized by a ragtag group of ALS patients who connected mostly through Facebook, and it’s far less a production than other efforts like the 2014 ice bucket challenge that swept around the world.

          advertisement

          These protesters haven’t even established a formal organization or a website; some said they’ve never even been to a protest. There’s nary a poster board in sight, yet.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

          GwenPetersen,38,anALSpatient,believesthattherecentfailureofAmylyx'sdrugRelyvriocouldstillteachresear

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Having children helps parents live longer, especially after age 80

          SeanGallup/GettyImagesGutChecklooksathealthclaimsmadebystudies,newsmakers,orconventionalwisdom.Weask